board members

• Molly Lindquist, Founder and CEO

  Molly Lindquist, Founder and CEO

  
  

  Molly Lindquist, a mom and breast cancer survivor, founded Consano, a 501(c)(3) crowdfunding platform for medical research, after her cancer diagnosis in 2011 at the age of 32. Molly graduated from Stanford University with a degree in economics and went on to work as an investment banking analyst in the consumer group at Robertson Stephens. After her stint in banking, Molly transitioned into the corporate world, travelling the globe sourcing products for World Market and then doing company planning for the Banana Republic brand of Gap Inc. After the birth of her first child in 2006, Molly took on the most difficult job she’s ever had as a stay-at-home mom, and learned that there was no Excel model that could map out the whims of a small child. The complexity and joy of work only grew in 2008 when her second daughter joined the family. Molly blogs about her cancer experience for the Huffington Post and was named a 2014 Knowledge Networks Rising Star by Portland Monthly magazine, a 2014 Orchid Award Winner and a 2015 “40 Under 40” award recipient by the Portland Business Journal and a 2015 Honoree of “the one hundred.” She is also the proud recipient of a “Best Mom in the World” mug.

• Greg Butz

  Greg Butz

  
  

  Greg is an investor at Asymmetry Global Healthcare, a healthcare-dedicated hedge fund based in San Francisco. Prior to Asymmetry, Greg was a healthcare investment banker and a sellside equity research associate. Greg has an undergraduate degree from Williams College and a MBA from the Tuck School at Dartmouth.
• Scott Finkelstein

  Scott Finkelstein

  
  

  Scott practices pediatric and trauma anesthesiology with the Oregon Anesthesiology Group. Scott obtained a B.A. in Human Biology at Stanford, earned an M.D. from UCSF, and completed residency training in the UCSF Department of Anesthesiology, where he was awarded the Stuart C. Cullen award for clinical excellence. 

• Larissa Fontaine

  Larissa Fontaine

  
  

  Larissa is excited to be a part of the Consano team, contributing her technology and partnership experience from various roles at Google, Amazon, and now YouTube. She is inspired by Consano’s mission to create a platform that empowers individuals to directly support meaningful medical research and ultimately change lives for generations to come.  Technology is a great enabler, often for entertainment but also for important social impact – she is incredibly thankful that it will now serve to deeply connect and engage a community committed to advancing medical progress. Larissa has English and Mechanical Engineering degrees from Stanford University and an MBA from the Stanford Graduate School of Business. 

• 

• Anisha Ambardar Goodly

  Anisha Ambardar Goodly

  
  

  Anisha is a Managing Director at Trust Company of the West (TCW), an asset manager based in Los Angeles. At TCW, she serves as the Emerging Markets Portfolio Specialist and is responsible for the team's marketing and client services efforts. Prior to joining TCW, Anisha spent eleven years at Morgan Stanley in New York, primarily in Fixed Income Research and Sales. She received a BA in Economics from Stanford University. Anisha is thrilled to be a part of the Consano team. She too has seen firsthand the devastating effects of disease and is honored to work on such a groundbreaking new approach to medical research funding. In her spare time, Anisha enjoys running, hiking, and writing.  

• Amber Huffman

  Amber Huffman

  
  

  Amber Huffman is a technologist at Intel where she leads industry storage standards. She is passionate about helping the next generation of women grow to senior leadership levels in high tech. She received a BSE in Computer Engineering from the University of Michigan, an MSE in Electrical Engineering from Stanford, and has been awarded 22 patents. Amber is committed to helping others with challenging health conditions, after being diagnosed with ovarian cancer in 2014 at the age of 36. Amber is thrilled to be part of the team, where she can draw on her experience in technology and as a cancer survivor, to help Consano make a difference. 

• Christina Kloss

  Christina Kloss

  
  

  Christina is an anesthesiologist with the Oregon Anesthesiology Group where she practices pediatric, adult, and trauma anesthesia at Legacy Emanuel Medical Center, a Level 1 trauma center in Portland, Oregon. Christina grew up in Milwaukee, WI, and moved to Portland in 2008 for her Anesthesiology residency training at OHSU. Prior to that, she obtained a B.S. in Exercise Science/Kinesiology and earned an M.D. from the University of Wisconsin – Madison. Christina is a rising leader who has grown OAG’s resident education program with the OHSU Department of Surgery. She is honored to be a part of Consano, and loves the simplistic and transparent approach of linking innovative and enthusiastic medical researchers with everyday people wanting to do their part to advance medical research. 

• Holly Levow

  Holly Levow

  
  

  As a California licensed attorney and business woman, Holly Levow used to spend her days in high technology start-up companies in Silicon Valley doing a variety of work including Contract Law, Business Development, HR and Marketing. Today, her profession is a full-time mother while also undertaking projects with a social mission. Holly is an active Partner with Social Venture Partners Portland (SVP), an engaged venture philanthropy organization focused on strengthening Portland nonprofits that are serving our most vulnerable kids. Holly truly believes in Consano's potential for great social impact and is excited to be a part of the Consano community! Holly received her BS in Mathematics and her JD/MBA from Santa Clara University.

• 

• Lindsay Stamm

  Lindsay Stamm

  
  

  Lindsay is drawn to Consano’s mission after watching her beloved parents lose their lives to cancer. Her mom courageously fought ovarian cancer for eight years. Her father valiantly battled against an aggressive form of melanoma. Inspired by her parents, Lindsay is committed to supporting research with the hopes that better treatments, and ultimately a cure, will be found. For the past several years, Lindsay worked as an attorney in Portland and has volunteered with Legal Aid’s Senior Law Project, Children’s Cancer Association, Mercy Corps, and the Melanoma Research Foundation. Lindsay has also worked in the U.S. Senate as a legislative aide.

• Richard White

  Richard White

  
  

  Dr. Richard White is an Assistant Member in the Department of Cancer Biology & Genetics at Memorial Sloan-Kettering Cancer Center and an Assistant Professor at Weill-Cornell Medical College. After training as an M.D./Ph.D. at Albany Medical College, he pursued clinical training in Internal Medicine at Yale-New Haven Hospital, where he also served as a Chief Resident. This was followed by a medical oncology fellowship at the Dana-Farber Cancer Institute/Massachusetts General Hospital. He did his postdoctoral research work in the laboratory of Dr. Leonard Zon at Children’s Hospital Boston and the Harvard Medical School, where he pioneered the use of zebrafish as a model to study cancer.  In recent years, the zebrafish has emerged as an increasingly important model for cancer biology because of its unique capacity for screening of new cancer genes and pathways.  At Sloan Kettering, he sustains a highly successful laboratory program while maintaining a clinical presence. His research focuses on the mechanisms by which cancers, especially melanoma and pancreatic, acquire metastatic capacity, the cause of nearly all cancer deaths.  He uses the zebrafish for these studies because they are optically transparent, and breed in large numbers, allowing him to take unbiased approaches to find novel drivers of metastasis.  Combined with its strengths in transgenic technology and in vivo imaging, he has addressed the genetic underpinnings of metastasis, considering both the tumor cell as well as the host genetic background. His goal is to identify the molecular mechanisms that allow tumors to evolve and to determine whether such mechanisms could be exploited therapeutically.

•